close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Coya Therapeutics

Recent news which mentions Coya Therapeutics

Coya Therapeutics Secures Key Financing In Its Fight Against Myriad Diseases
Tickers COYA
Tags COYA Market News General
From Benzinga
Coya Therapeutics Secures Key Financing In Its Fight Against Myriad Diseases
Tickers COYA
Tags Coya Therapeutics General Benzinga
From Benzinga
Coya Therapeutics sees strong quarter of presenting data of investigator-initiated clinical studies
Tags Coya Therapeutics XNAS:COYA
From TheNewswire.com - RSS (Media)
Headline
Tags XNAS:COYA Coya Therapeutics
From TheNewswire.com - RSS (Media)
Positive Financials Along With Promising Clinical Results – Coya Therapeutics
Tickers COYA
Tags Movers & Shakers Market News COYA
From Benzinga
Alzheimer's Disease Largely Remains A Mystery, With A Lack Of Highly Effective Treatments — Could Regulatory T-Cells (Tregs) Be The Answer?
Tickers COYA LLY NVS
Tags Coya Therapeutics Penny Stocks Benzinga
From Benzinga
There Is No Cure For ALS, But Coya Therapeutics Might Have The Answer According To A New Clinical Study
Tickers COYA
Tags Coya Therapeutics Penny Stocks Benzinga
From Benzinga
Coya Therapeutics: This BioPharma Company Has Some Big News To Share
Tickers COYA
Tags News General Benzinga
From Benzinga
Coya Therapeutics Enters First-Of-Its-Kind Partnership With Multi-Billion Dollar Drug Company — Why This Is A Major Moment For Drug Development
Tickers BLUE COYA GOVX LLY
Tags LLY Small Cap Benzinga
From Benzinga
Coya Therapeutics' COYA 302 Treating ALS Proves Effective In Proof-Of-Concept Academic Clinical Study
Tickers COYA
Tags Biotech Partner Content COYA
From Benzinga
Houston-Based Coya Therapeutics Partners With Multi-Billion Dollar Global Drug Company Dr. Reddy's Laboratories To License And Commercialize COYA 302
Tickers COYA RDY
Tags Partner Content COYA Market News
From Benzinga
This Company Is Focused on Treg-Enhancing Therapies - Could This Be Medicine's Next Frontier?
Tickers COYA LLY NVS
Tags NVS Biotech Partner Content
From Benzinga
Houston-Based Coya Therapeutics To Present Results From ALS Clinical Study Data For Its Investigational Biologic Combination at the 2023 MDA Clinical & Scientific Conference in Dallas
Tickers COYA
Tags Market News Partner Content COYA
From Benzinga
Coya Therapeutics' Expansion Of Exclusive Worldwide Licensing Agreement With ARscience Biotherapeutics Could Have Outsized Impact On Neurodegenerative And Autoimmune Diseases Treatments
Tickers COYA XGN
Tags Biotech Market News COYA
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today